Validation and interpretation of IGH and TCR clonality testing by Ion Torrent S5 NGS for diagnosis and disease monitoring in B and T cell cancersInvivoscribe Marketing2021-02-11T19:51:54-08:00November 25th, 2020|2020 Publications, Publications| Read more
Invivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-Therapieswmm2021-02-26T19:13:49-08:00March 28th, 2017|2017 Press Releases, Press Releases| Read more
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesInvivoscribe Marketing2021-02-12T20:42:59-08:00April 5th, 2014|Archived Publications, Publications| Read more